Douglass Winthrop Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Douglass Winthrop Advisors's BIIB Position: Q1 2019 in Review
Douglass Winthrop Advisors sold out of Biogen (BIIB) in Q1 2019, closing a stake of 1,392 shares — an estimated $419K sold.
Douglass Winthrop Advisors first reported a position in BIIB in Q2 2013 and held it in 23 quarters. The position peaked at $1.22M in Q2 2015. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.
- Douglass Winthrop Advisors reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
- Douglass Winthrop Advisors sold 1,392 Biogen shares in Q1 2019, an estimated $419K.
- Douglass Winthrop Advisors first reported a position in Biogen in Q2 2013 and held it in 23 quarters.
- Douglass Winthrop Advisors's Biogen position peaked at $1.22M in Q2 2015.
- 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.
Based on Douglass Winthrop Advisors's 13F filing for Q1 2019, filed 9 Apr 2019.